Find clinical trials for Breast Cancer in St Louis, MO
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Breast Cancer trials near St Louis, MO, USA:
This trial studies the efficacy and safety of cryoablation in patients with low risk, early stage breast cancer. Cryoablation is a ...
Saint Louis, Missouri, United States
The purpose of this study is to find out the possible anti-cancer effect of pelareorep in combination with chemotherapy \[paclitaxel\] and a ...
Phase 2
Saint Louis, Missouri, United States and 17 other locations
to anti-HER2-based therapy plus endocrine therapy alone in improving the outcomes of subjects with hormone receptor-positive, HER2+ metastatic breast...
Phase 3
Saint Louis, Missouri, United States and 106 other locations
This study will compare DS 8201a to standard treatment.Participants must have HER2 breast cancer that has been treated before.Their ...
Phase 3
St Louis, Missouri, United States and 226 other locations
with NECTIN4-amplified recurrent, unresectable, or metastatic breast cancer who have received prior therapy (see inclusion criteria...
Phase 2
St Louis, Missouri, United States and 34 other locations
to see if it can be a possible treatment for advanced metastatic breast cancer. This type of cancer would have spread from...
Phase 1, Phase 2
St Louis, Missouri, United States and 22 other locations
A study to learn about a new medicine called ARV-471 (PF-07850327) in people who have advanced metastatic breast cancer....
Phase 3
Saint Louis, Missouri, United States and 316 other locations
OR in combination with Hormonal Therapy in subjects with HR+, HER2- locally advanced and unresectable (Stage III) or metastatic (Stage IV) breast...
Phase 1
Saint Louis, Missouri, United States and 7 other locations
postmenopausal women with locally advanced or metastatic ER+/HER2- breast cancer with an acquired ESR1 mutation and who have diseas...
Phase 2
Saint Louis, Missouri, United States and 50 other locations
This study will look to establish the recommended biologic dose of AE37 in combination with pembrolizumab that will enhance the tumor-specif ...
Phase 2
Swansea, Illinois, United States and 5 other locations
Clinical trials
Research sites
Resources
Legal